Menu
Annual · values202520242023202220212020201920182017201620152014
Operating Cash Flow-8.57 M USD-8.64 M USD-14.12 M USD-10.26 M USD-10.13 M USD-9.11 M USD-6.43 M USD-9.35 M USD-4.68 M USD-7.17 M USD-9.06 M USD-14.52 M USD
Depreciation & Amortization319000 USD842000 USD907000 USD335000 USD185000 USD78000 USD102000 USD105000 USD578000 USD1.44 M USD1.65 M USD1.84 M USD
Stock-Based Compensation1.39 M USD82000 USD291000 USD369000 USD309000 USD45000 USD2000 USD42000 USD219000 USD273000 USD911000 USD10.22 M USD
Capital Expenditures185000 USD690000 USD530000 USD1.41 M USD3.74 M USD360000 USD147000 USD11000 USD1.19 M USD671000 USD695000 USD2.17 M USD
Cash Flow from Investing913000 USD-194000 USD-501000 USD-1.10 M USD-1.65 M USD1.75 M USD1.38 M USD-145000 USD-1.14 M USD-617000 USD-658000 USD-1.74 M USD
Cash Flow from Financing8.20 M USD9.09 M USD11.71 M USD3.34 M USD705000 USD30.93 M USD1.39 M USD14.40 M USD-559000 USD3.22 M USD2.96 M USD32.23 M USD
Dividends Paid
Stock Buybacks133000 USD120000 USD
Free Cash Flow-8.76 M USD-9.33 M USD-14.64 M USD-11.67 M USD-13.87 M USD-9.47 M USD-6.58 M USD-9.36 M USD-5.87 M USD-7.84 M USD-9.76 M USD-16.69 M USD

Sintx Technologies Inc. is an advanced ceramics company specializing in the research, development, and commercialization of silicon nitride-based medical devices and biomaterials. It manufactures solid and porous silicon nitride products, silicon nitride powder, coatings, and composite materials including polyether ether ketone and polyetherketoneketone for biomedical, technical, and antipathogenic applications. The company offers innovative solutions such as the FDA-cleared SINAPTIC Foot & Ankle Osteotomy Wedge System and OsseoSculpt biologic, which feature pro-osteogenic, bacteriostatic, and enhanced imaging properties. Sintx Technologies Inc. also develops antipathogenic fibrous materials and fabrics for medical textiles, wound dressings, filtration, PPE, and high-touch surfaces, supported by composition and method patents. Recent advancements include the SiN/PEEK compound produced via partnerships for AI-assisted, 3D-printed patient-specific implants targeting orthopedic, spine, and reconstructive surgery markets. Founded in 1996 and headquartered in Salt Lake City, Utah, Sintx Technologies Inc. focuses on infection-resistant devices, polymer composites, and licensing opportunities in the medical device sector.